Nuvectis Cash from 2010 to 2025
| NVCT Stock | USD 6.74 0.37 5.81% |
Cash | First Reported 2010-12-31 | Previous Quarter 22 M | Current Value 13.9 M | Quarterly Volatility 6 M |
Check Nuvectis Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nuvectis Pharma's main balance sheet or income statement drivers, such as Interest Expense of 179.9 K, Selling General Administrative of 4.6 M or Selling And Marketing Expenses of 13.2 K, as well as many indicators such as Price To Sales Ratio of 510, Dividend Yield of 0.0 or PTB Ratio of 10.05. Nuvectis financial statements analysis is a perfect complement when working with Nuvectis Pharma Valuation or Volatility modules.
Nuvectis | Cash |
Latest Nuvectis Pharma's Cash Growth Pattern
Below is the plot of the Cash of Nuvectis Pharma over the last few years. Cash refers to the most liquid asset of Nuvectis Pharma, which is listed under current asset account on Nuvectis Pharma balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Nuvectis Pharma customers. The amounts must be unrestricted with restricted cash listed in a different Nuvectis Pharma account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Nuvectis Pharma's Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nuvectis Pharma's overall financial position and show how it may be relating to other accounts over time.
| Cash | 10 Years Trend |
|
Cash |
| Timeline |
Nuvectis Cash Regression Statistics
| Arithmetic Mean | 8,995,858 | |
| Geometric Mean | 7,692,512 | |
| Coefficient Of Variation | 66.93 | |
| Mean Deviation | 4,880,787 | |
| Median | 5,742,000 | |
| Standard Deviation | 6,021,014 | |
| Sample Variance | 36.3T | |
| Range | 16.3M | |
| R-Value | 0.71 | |
| Mean Square Error | 19.3T | |
| R-Squared | 0.50 | |
| Significance | 0 | |
| Slope | 896,144 | |
| Total Sum of Squares | 543.8T |
Nuvectis Cash History
Other Fundumenentals of Nuvectis Pharma
| Cash And Short Term Investments | ||
| Change In Cash | ||
| Free Cash Flow | ||
| Other Cashflows From Financing Activities |
Nuvectis Pharma Cash component correlations
Click cells to compare fundamentals
About Nuvectis Pharma Financial Statements
Nuvectis Pharma shareholders use historical fundamental indicators, such as Cash, to determine how well the company is positioned to perform in the future. Although Nuvectis Pharma investors may analyze each financial statement separately, they are all interrelated. The changes in Nuvectis Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on Nuvectis Pharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Cash | 22 M | 13.9 M | |
| Cash And Short Term Investments | 22 M | 13.9 M | |
| Change In Cash | -997 K | -947.2 K | |
| Free Cash Flow | -14.4 M | -15.1 M | |
| Other Cashflows From Financing Activities | 11.3 M | 11.8 M | |
| Other Non Cash Items | -125.1 K | -131.4 K | |
| Total Cash From Operating Activities | -14.4 M | -15.1 M | |
| Total Cash From Financing Activities | 17.4 M | 20.2 M | |
| End Period Cash Flow | 22 M | 12.3 M | |
| Begin Period Cash Flow | 23 M | 12.1 M | |
| Cash And Cash Equivalents Changes | 12.8 M | 11.4 M | |
| Cash Flows Other Operating | -288.9 K | -303.3 K | |
| Free Cash Flow Yield | (0.14) | (0.15) | |
| Operating Cash Flow Per Share | (1.18) | (1.24) | |
| Free Cash Flow Per Share | (1.18) | (1.24) | |
| Cash Per Share | 1.11 | 0.87 | |
| EV To Operating Cash Flow | (7.97) | (7.57) | |
| EV To Free Cash Flow | (7.97) | (7.57) | |
| Price To Operating Cash Flows Ratio | (9.35) | (8.88) | |
| Price To Free Cash Flows Ratio | (9.35) | (8.88) | |
| Cash Ratio | 2.46 | 2.22 | |
| Cash Conversion Cycle | (50.80) | (53.34) | |
| Price Cash Flow Ratio | (9.35) | (8.88) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Nuvectis Stock Analysis
When running Nuvectis Pharma's price analysis, check to measure Nuvectis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuvectis Pharma is operating at the current time. Most of Nuvectis Pharma's value examination focuses on studying past and present price action to predict the probability of Nuvectis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuvectis Pharma's price. Additionally, you may evaluate how the addition of Nuvectis Pharma to your portfolios can decrease your overall portfolio volatility.